nab -Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

nab -Paclitaxel, cisplatin, and 5-fluorouracil followed by concurrent cisplatin and radiation for head and neck squamous cell carcinoma

Published:2016-10 Issue: Volume:61 Page:1-7
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Adkins Douglas,Ley Jessica,Michel Loren,Wildes Tanya M.^ORCID,Thorstad Wade,Gay Hiram A.,Daly Mackenzie,Rich Jason,Paniello Randal,Uppaluri Ravindra,Jackson Ryan^ORCID,Trinkaus Kathryn,Nussenbaum Brian

Funder

NCI Cancer Center

Celgene

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference33 articles.

1. National Comprehensive Cancer Network. Head and Neck Cancers (Version 1.2015). [accessed April 11, 2016].

2. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer;Forastiere;N Engl J Med,2003

3. Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer;Vermorken;N Engl J Med,2007

4. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007

5. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck;Bonner;N Engl J Med,2006

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for locally advanced head and neck squamous cell carcinoma;Holistic Integrative Oncology;2024-06-27

2. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

3. A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The “ALARM” study;Cancer Medicine;2024-01-21

4. Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?;Critical Reviews in Oncology/Hematology;2023-06

5. A systematic literature review of the HPV prevalence in locally-regionally advanced (LA) and recurrent/metastatic (RM) head and neck cancers through the last decade: The ‘ALARM’ study;2023-03-09